Is Molnupiravir the Key to Ending the Pandemic?
Molnupiravir, a new drug from Merck pharmaceuticals, is proving effective in treating patients diagnosed with Covid-19. Is this the tool necessary to defeat the pandemic once and for all?
Clinical trials showed that the drug reduced the risk of hospitalization and death in at-risk patients by 50 percent, according to the company’s interim analysis.
Although experts predict COVID-19 will become endemic, with an oral, safe, and effective drug available, many sectors of the economy such as hospitality and travel should be able to return to near-normal, pre-pandemic operations.
Available COVID-19 treatments are a miracle for infected patients and should be widely available to people at an affordable cost — but they are a second line of defense. Vaccines are a miracle for everyone…